Cartesian Therapeutics
RNAC
46 hedge funds and large institutions have $124M invested in Cartesian Therapeutics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 7
7% more funds holding
Funds holding: 43 → 46 (+3)
1.74% more ownership
Funds ownership: 44.96% → 46.7% (+1.7%)
12% less capital invested
Capital invested by funds: $140M → $124M (-$16.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SRF
Silver Rock Financial
Los Angeles,
California
|
+$3.03M |
| 2 |
BlackRock
New York
|
+$2.92M |
| 3 |
DM
Deerfield Management
New York
|
+$2.9M |
| 4 |
Millennium Management
New York
|
+$1.61M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$925K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$1.65M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.35M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$561K |
| 4 |
HC
Hillman Company
Pittsburgh,
Pennsylvania
|
-$290K |
| 5 |
JP Morgan Chase
New York
|
-$221K |
RNAC Hedge Fund Activity: Q1 2017 in Review
46 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Cartesian Therapeutics (RNAC) for Q1 2017, worth a combined $124M — down 12% from $140M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new RNAC positions and 4 closed out — a net gain of 7 holders — while 14 added to existing stakes and 7 trimmed.
The largest buyer was Silver Rock Financial, adding an estimated $3.03M. The largest seller was State of Michigan Retirement System, exiting entirely with an estimated $1.65M sold.
- 46 institutional investors held Cartesian Therapeutics (RNAC) as of Q1 2017, up from 43 in Q4 2016.
- Funds reported $124M of Cartesian Therapeutics stock for Q1 2017, down 12% quarter-over-quarter.
- 11 funds opened new Cartesian Therapeutics positions in Q1 2017 and 4 closed out, a net change of +7 holders.
- The largest Cartesian Therapeutics buyer in Q1 2017 was Silver Rock Financial, an estimated $3.03M added.
- The largest Cartesian Therapeutics seller in Q1 2017 was State of Michigan Retirement System, an estimated $1.65M sold.
Based on aggregated 13F filings for Q1 2017.